To counter these challenges, CELFULL's research team has developed a microencapsulated form of NADH. This innovative formulation enhances NADH's stability, making it acid-resistant and enabling targeted release in the intestine. This breakthrough is protected by patents (Patent numbers ZL202110819545.5 and 11744804).
As a leader in the mass production of high-quality NADH microcapsule powder, CELFULL is dedicated to supporting the scientific community. We provide our stable NADH microcapsule powder to academic research groups engaged in NADH-related research. By donating these advanced materials, we aim to foster both academic advancement and industry development.